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Abstract  
 
Extensive research has related specific lesion locations to language impairment in aphasia. 
However, far less work has focused on the patterns of brain damage that predict prognosis in 
aphasia. The current study examined brain damage as a predictor of language recovery in acute 
patients with aphasia caused by stroke. Damage to the left posterior middle temporal gyrus 
(MTG) and left pars triangularis predicted poor recovery of speech production and MTG 
damage predicted less recovery of speech comprehension. These findings suggest that brain 
changes associated with language recovery rely on preservation and recruitment of the 
aforementioned areas in the left hemisphere.  
 
Introduction  
 
Recovery from stroke can vary substantially among patients, even in cases where the initial 
severity of impairment may be similar (Lazar & Antoniello 2008; Lazar et al., 2008). The 
prognosis for aphasia recovery depends in large part upon the underlying etiology and location 
and extent of brain damage (Pedersen et al., 1995). Most patients with post-stroke aphasia 
improve to some extent (e.g. Inatomi et al., 2008; Berthier, 2005; Wade et al., 1986; Pedersen et 
al., 1995; Ashtary et al., 2006; Laska et al., 2001), but some only make minimal improvement. 
The severity of the initial aphasia strongly correlates with the long-term deficit; those with 
milder degrees of aphasia at onset are the most likely to recover completely (Pedersen et al., 
2004; Bakheit et al., 2007; Lazar et al., 2010).  
Advances in neuroimaging have greatly improved our understanding of stroke not only in 
the acute, but also in the subacute and chronic stages of recovery. MRI and computed 
tomography allow clinicians to more accurately diagnose stroke subtypes, optimize treatment, 
and predict prognosis. Thus, neuroimaging in stroke may also be utilized to monitor response to 
both medical treatment as well as physical rehabilitation (Gale & Pearson, 2012). Although some 
early studies may have argued that lesion volume was likely to be more important than lesion 
location when predicting outcome (e.g. see Brott et al., 1989), more recent studies have 
increasingly demonstrated the importance of lesion location (Gale & Pearson, 2012). 
In the current study we sought to determine sites and extent of brain damage that 
predicted less aphasia recovery as determined by neuropsychological testing.  
 
Method 
 
Participants. The participants included in this study were 34 stroke patients (female=18; mean 
age = 67.78; range = 40-79 at time of recruitment) admitted to the Landspitali – University 
Hospital in Reykjavik, Iceland. All participants had incurred a single event ischemic stroke to the 
left hemisphere and provided informed consent for study inclusion.  
Participants did not need to present with aphasia to qualify for this study. All participants were 
tested at the acute phase of stroke and again at chronic phase of stroke (2-5 years post-onset). 
 
Procedure. All participants were administered a neuropsychological workup, which included the 
Bedside Evaluation Screening Test, 2nd edition (BEST-2; West, Sands, & Ross-Swain, 1998). 
The BEST-2’s Conversational expression sub-test served to quantify the severity of speech 
production impairment and the “Pointing to Parts of Picture” subtest served to quantify the 
severity of speech comprehension impairment. Each subtest includes five items where the level 
of presentation of each item is titrated based on patients’ success with the previous item. Each 
item includes: 1) complete sentence; 2) phrase; 3) single word. Based on the BEST-2 overall 
aphasia severity scale, six patients had severe language impairment, eight had moderate 
impairment, while twenty patients presented with mild or no language impairment. At time of 
retesting only one person had severe language impairments, three had moderate impairments and 
thirty patients presented with mild or no language impairment. See table 1 for demographic 
information, test scores and severity scores. 
 
All participants underwent a 1.5T MRI scanning sequences (using a Siemens Avanto system) 
that included T1, T2* and diffusion weighted imaging (DWI) sequences. For the purpose of 
predicting recovery based on lesion location, the location and extent of brain damage was 
demarcated on the DWI scans by a neurologist with extensive experience using this 
methodology.  
 
Data Analysis. A voxelwise correlation analysis of structural damage as a predictor of recovery 
was conducted in MATLAB (Mathworks, Inc.) via custom software. The dependent factor was 
change in scores on the two subtests; the independent factor was structural damage as 
demarcated on T2-MRI. In order to control for severity of the initial language impairment, 
baseline scores were included in the model as a cofactor. The crucial question here was whether 
patients with common damage to specific brain region(s) tended to make less recovery compared 
to those patients in which the same region remained intact following stroke.  
 
Results  
 
Damage to the left posterior middle temporal gyrus (MTG) and left pars triangularis was found 
to predict less recovery on subtest 1, Conversational Expression, on the BEST-2. Damage to a 
similar, but distinct region in the left posterior MTG was associated with less recovery on subtest 
6, Pointing to parts of picture, on the same test (Figure 1). 
 
Discussion  
 
The application of neuroimaging has revealed much about the physiology of early stroke 
recovery, including that of aphasia. Although it is not entirely clear how this informs early 
treatment of aphasia, it is possible that a better understanding of the neurophysiological 
dynamics of stroke will allow us to manage our resources better during each phase of recovery 
and thereby maximize long-term aphasia recovery. For patients with chronic aphasia, 
neuroimaging has revealed that successful aphasia treatment, along with improving 
communication ability, does influence both brain function and brain structure. Although the 
obvious goal of aphasia treatment is to improve the patients' ability to communicate, 
understanding how aphasia treatment influences the brain may, in turn, improve the selection of 
the specific treatment approach.  
 
Our findings suggest that brain changes associated with recovery of both speech production and 
comprehension rely on preservation and recruitment of aforementioned areas of cortex in the left 
hemisphere. In general, it also seems likely that a similar relationship between cortical 
preservation and recruitment may also pertain to recovery from other functional impairments in 
chronic stroke. Our findings contribute to research regarding the neuroanatomical mechanism of 
aphasia recovery, and may ultimately improve its treatment.  
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Figure 1. Areas that predict less recovery. For the conversational expression measure, there are 
clusters (red in image) in pars triangularis (BA45) and the posterior middle temporal lobe 
(BA21) where damage predicts less recovery, and for the pointing to parts of picture measure, 
there is one cluster (blue in image) in the posterior middle temporal lobe (also BA21) where 
damage predicts less recovery. 
 
 
  
Table 1. Demographic information and BEST-2 scores at baseline-retesting for all patients. 
Individual scores for the two subtests are raw scores. The Quotient is a sum of standard scores 
for all subtests and the severity score for each patient is based on the Quotient. 
 
   BASELINE  RETEST  
Patient Age Gender Subtest 1 Subtest 6 Quotient Severity Subtest 1 Subtest 6 Quotient Severity 
1 56 F 30.00 30.00 116.00 none/mild 30.00 30.00 115.00 none/mild 
2 54 F 29.00 29.00 110.00 none/mild 30.00 30.00 114.00 none/mild 
3 56 M 28.00 30.00 111.00 none/mild 30.00 30.00 117.00 none/mild 
4 44 F 24.00 30.00 101.00 moderate 30.00 30.00 120.00 none/mild 
5 46 F 30.00 30.00 113.00 none/mild 30.00 30.00 120.00 none/mild 
6 59 M 30.00 30.00 120.00 none/mild 30.00 30.00 120.00 none/mild 
7 62 M 12.00 20.00 83.00 severe 26.00 24.00 96.00 moderate 
8 75 M 30.00 30.00 123.00 none/mild 30.00 30.00 123.00 none/mild 
9 75 F 23.00 20.00 100.00 moderate 30.00 29.00 118.00 none/mild 
10 67 F 0.00 30.00 96.00 moderate 29.00 28.00 102.00 moderate 
11 56 M 30.00 28.00 107.00 moderate 30.00 30.00 114.00 none/mild 
12 61 F 30.00 30.00 120.00 none/mild 30.00 30.00 121.00 none/mild 
13 60 M 0.00 18.00 75.00 severe 26.00 28.00 103.00 moderate 
14 45 F 30.00 30.00 117.00 none/mild 30.00 30.00 115.00 none/mild 
15 72 F 28.00 25.00 103.00 moderate 30.00 28.00 116.00 none/mild 
16 65 M 30.00 30.00 121.00 none/mild 30.00 30.00 120.00 none/mild 
17 75 M 30.00 30.00 121.00 none/mild 30.00 30.00 123.00 none/mild 
18 61 F 30.00 29.00 104.00 moderate 30.00 30.00 119.00 none/mild 
19 68 M 0.00 0.00 70.00 severe 24.00 30.00 117.00 none/mild 
20 62 M 30.00 30.00 116.00 none/mild 30.00 30.00 117.00 none/mild 
21 74 F 30.00 30.00 120.00 none/mild 30.00 30.00 119.00 none/mild 
22 74 M 30.00 30.00 119.00 none/mild 30.00 30.00 125.00 none/mild 
23 72 F 30.00 30.00 112.00 none/mild 30.00 30.00 123.00 none/mild 
24 60 M 23.00 24.00 94.00 moderate 30.00 30.00 120.00 none/mild 
25 58 F 30.00 30.00 120.00 none/mild 30.00 30.00 120.00 none/mild 
26 70 M 30.00 30.00 121.00 none/mild 30.00 30.00 121.00 none/mild 
27 72 F 9.00 22.00 87.00 moderate 30.00 26.00 113.00 none/mild 
28 79 M 30.00 30.00 117.00 none/mild 30.00 30.00 119.00 none/mild 
29 65 M 30.00 30.00 117.00 none/mild 30.00 30.00 117.00 none/mild 
30 78 F 20.00 6.00 83.00 severe 30.00 28.00 115.00 none/mild 
31 65 F 30.00 21.00 104.00 moderate 30.00 30.00 121.00 none/mild 
32 63 M 4.00 17.00 79.00 severe 29.00 30.00 111.00 none/mild 
33 40 F 0.00 26.00 75.00 severe 26.00 26.00 84.00 severe 
34 77 F 30.00 22.00 115.00 none/mild 30.00 30.00 121.00 none/mild 
